Region Sjaelland — Sponsor Intelligence | 15 EU Trials

Filter these 15 trials by condition, phase, country and more.

Open in Search →

15 Registered trials

7 Recruiting

2 Completed trials

1 Countries active

17 Unique IMPs

100% Results reported

Phase II

Phase I/II

Phase IV

Phase I (Other)

Phase II: 7 Phase I/II: 2 Phase III/IV: 1 Phase IV: 2 Phase I (Other): 3

Oversight events:

1 temporary halt across 1 trial

View oversight register →

100%

2 of 2 completed trials have published summary results (EU CTR Article 37 — 12-month obligation).

View full Transparency Scoreboard →

Top indications

Bladder cancer 1 Caesarean section 1

Top IMPs

SODIUM CHLORIDE 4 AMOXICILLIN, CLAVULANIC ACID 1 ATORVASTATIN 1 BLEOMYCIN 1 CALCIUM FOLINATE PENTAHYDRATE 1 CAPECITABINE 1 CLINDAMYCIN 1 FERRIC DERISOMALTOSE 1 FLUOROURACIL 1 FOSFOMYCIN 1 METRONIDAZOLE 1 MOLGRAMOSTIM 1

All trials

15 total

Intraperitoneal treatment with fosfomycin, metronidazole and recombinant human granulocyte-macrophage colony-stimulating factor in patients … Not authorised

2024-520317-49-00 Phase I (Other) 1 country SODIUM CHLORIDE
Combination Therapy with Interferon-Alpha2a and Ruxolitinib in Newly Diagnosed Patients with Polycythemia Vera. A Danish Safety and Efficacy… Pending

2024-518216-39-00 Phase II 1 country RUXOLITINIB
Intraperitoneal treatment with fosfomycin, metronidazole and recombinant human granulocyte-macrophage colony-stimulating factor in patients … Pending

2024-520317-49-02 Phase I (Other) 1 country FOSFOMYCIN; METRONIDAZOLE; MOLGRAMOSTIM; SODIUM CHLORIDE
RESET C2 Pending

2026-525214-62-00 Phase II 1 country PEMBROLIZUMAB
Calcium Electroporation for Urinary Bladder Tumors: A First-in-Human Feasibility, Safety, and Early Response Trial - The CALCIFER Trial Pending

2026-526388-39-00 Phase I (Other) 1 country
MOTHER trial: Efficacy and safety of low-dose intrathecal morphine following planned caesarean section Recruiting

2024-518678-16-00 Phase IV 1 country
Atorvastatinbehandling til patienter med de Philadelphia-negative kronisk myeloproliferative neoplasier - essentiel trombocytose, polycythem… Recruiting

2024-518267-35-00 Phase II 1 country ATORVASTATIN
The BLESS Trial Recruiting

2024-513360-25-00 Phase III/IV 1 country
Tittle: Effects of intravenous administered iron in non-anemic iron deficient patients with colorectal cancer. A double blinded clinical ran… Recruiting

2024-518517-26-00 Phase II 1 country FERRIC DERISOMALTOSE; SODIUM CHLORIDE
A combined treatment with GM-CSF, fosfomycin and metronidazole for pouchitis in ulcerative colitis patients after restorative ileal pouch an… Recruiting

2024-517764-38-00 Phase I/II 1 country
HEMODIALYSIS AND ANTIBIOTIC PROPHYLAXIS Recruiting

2024-515001-26-00 Phase IV 1 country AMOXICILLIN, CLAVULANIC ACID; CLINDAMYCIN
Effect of low-dose Interferon-alfa2a on perioperative immune suppression Recruiting

2024-517619-65-00 Phase II 1 country PEGINTERFERON ALFA-2A; SODIUM CHLORIDE
NEOadjuvant chemotherapy only compared with standard treatment for Locally Advanced Rectal cancer: a randomized phase II trial Ended

2024-517748-76-00 Phase I/II 1 country CALCIUM FOLINATE PENTAHYDRATE; CAPECITABINE; FLUOROURACIL; OXALIPLATIN
Neoadjuvant electrochemotherapy for colorectal cancer - a phase 2 trial Halted

2025-520755-91-00 Phase II 1 country BLEOMYCIN
Blood vessel changes in regular skin cancer undergoing either electrochemotherapy or photodynamic therapy assessed with optical coherence to… Ended

2024-518228-63-01 Phase II 1 country

Showing 1–15 of 15 trials

← All sponsors A–Z